Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3231 - 3240 of 3721 results found

Systemic therapy for acute lymphoblastic leukemia (ALL)

MeSH Terms

Daunorubicin (D02.455.426.559.847.562.050.200); Precursor Cell Lymphoblastic Leukemia-Lymphoma (C15.604.515.560.600); Cyclophosphamide (D02.455.526.728.650.730.243); Cytarabine (D03.383.742.680.245.453)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2016

Systemic Therapy for Advanced Gastric and Gastro-Esophageal Carcinoma

MeSH Terms
stomach, gastric, gastroesophogeal, neoplasia, carcinoma, cancer, tumor, metastatic, malignancy, recurrent, advanced
Guideline Contact
Chika Arinze; [email protected]
Keywords
stomach, gastric, gastroesophogeal, neoplasia, cancer, recurrent, advanced
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date
2022-08-31
Date of Last Evidence Search
Jul-21
Methods Applied
Systematic review-based, Externally reviewed, Evidence quality assessment, GRADE approach
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2022

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

MeSH Terms
Carcinoma; Hepatocellular (C04.588.274.623.160) Neoplasms (C04)
  • Neoplasms by Site (C04.588)
    • Digestive System Neoplasms (C04.588.274)
      • Liver Neoplasms (C04.588.274.623)
        • Carcinoma, Hepatocellular (C04.588.274.623.160)
Guideline Contact
[email protected]
Date for Review
22-Nov
Publication Date
16-Nov-20
Date of Last Evidence Search
15-May-20
Publication Scope
treatment
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2020

Systemic therapy for advanced or recurrent endometrial cancer, and advanced or recurrent uterine papillary serous carcinoma

MeSH Terms

Endometrial Neoplasms (C04.588.945.418.948.585); Uterine Neoplasms (C04.588.945.418.948); Drug Therapy (E02.319); Drug Therapy; Combination (E02.319.310); Antineoplastic Agents (D27.505.954.248)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2017

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Guideline Contact
Judy Brown; [email protected]
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date
09/08/2022
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Publication Year
2022

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update

MeSH Terms
Neoplasms (C04); Breast Neoplasms (C04.588.180); Pharmacologic Actions (D27.505)
Guideline Contact
[email protected]
Publication Date
25-Jun-18
Publication Scope
prognosis
treatment
Countries of Application
United States
Guideline Publication Status
Under Review
Languages
English
Authors
ASCO (US)
Publication Year
2018